COMING SOON!
We are currently negotiating funding agreements with the majority of Health Funds to enable Kinship to provide gap-free, hospital excess-free services to most insured patients over the coming months.
We’re also working on other sources of funding for uninsured patients. We’ll update the below table as new agreements are signed, so please check back later if your patient is not currently eligible for one of our funding sources
| Treatment type | ||||
Funding source: Private |
Cytotoxic chemotherapy (subcutaneous) |
Cytotoxic chemotherapy (intravenous) |
Immuno-oncology (intravenous) |
Other infusions (intravenous) |
| Private |  Nationwide |
|||
| Treatment type | ||||
Funding source: Health Funds* |
Cytotoxic chemotherapy (subcutaneous) |
Cytotoxic chemotherapy (intravenous) |
Immuno-oncology (intravenous) |
Other infusions (intravenous) |
 |
Nationwide |
|||
 |
 ACT, NSW, QLD |
|||
 |
Nationwide |
|||
*For eligible members: Fund, policy, wait period and program eligibility rules apply. Must serve as a substitute for an episode of admitted in-hospital treatment which could not otherwise reasonably be provided as an ambulatory or outpatient setting.